Forecast: Diabetes Medicine Use in Türkiye (Turkey)

In Turkey, the use of diabetes medicine has shown a consistent increase from 2013 to 2023, reaching 105.1 Defined Daily Dosages per thousand persons per day in 2023. The year-on-year variation has fluctuated, with notable spikes in 2017 and 2020, where the year-on-year growth was 9.17% and 16.18%, respectively. Over the last ten years, there has been an average growth (CAGR) of approximately 6.87% per year. This steady increase highlights the growing prevalence of diabetes and the corresponding rise in treatment utilization.

Future trends to watch for:

- Continued increase in diabetes medicine use, with a forecasted CAGR of 2.96% over the next five years.

- Monitoring the impact of healthcare policies, public health initiatives, and innovations in diabetes treatment on medicine use.

- Potential variations in the usage patterns influenced by lifestyle changes, awareness campaigns, and advancements in medical technology.